featured
Pembrolizumab, Pomalidomide and Low Dose Dexamethasone for Relapsed/Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab, Pomalidomide and Low Dose Dexamethasone for Relapsed/Refractory Multiple Myeloma
Blood 2017 May 01;[EPub Ahead of Print], A Badros, E Hyjek, N Ma, A Lesokhin, A Dogan, AP Rapoport, M Kocoglu, E Lederer, S Philip, T Milliron, C Dell, O Goloubeva, Z SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.